<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>前免疫</title><link/>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%20%5BNLMID%5D&amp;ff=2025028091008&amp;utm_camp aign =日记＆utm_source = chrome＆v = 2.18.0.post9+e462414＆utm_content = 101560960＆fc = none＆utm_medium = rss<description>前免疫：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;ff=20250228091008&amp;utm_campaign=journals&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_content=101560960&amp;fc=None&amp;utm_medium=rss" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期五，2025年2月28日14:10:08 +0000</lastbuilddate><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><ttl> 120</ttl><item><title> ITGAV在消化系统癌症进展和免疫浸润中的多面作用的全面分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018050/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>结论：我们的结果阐明了ITGAV在预后评估，早期诊断和对消化系统癌症的免疫疗法中的重要性，并揭示了其在调节癌症进展中的多方面作用。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1480771。 doi：10.3389/fimmu.2025.1480771。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：消化系统癌症是最常见的恶性肿瘤之一，表现出始终高的发病率和死亡率，但有效的检测和治疗靶标仍然有限。整联蛋白αV（ITGAV，CD51）是整联蛋白家族的重要成员，以其在介导细胞与细胞外基质之间的相互作用以及细胞内信号传导中的作用而广泛认可。近年来，在多种肿瘤（例如前列腺癌，乳腺癌和骨肉瘤）中，ITGAV的表达显着升高，并且被认为是肿瘤进展各个阶段的关键组成部分。但是，尚未进行系统的消化系统癌症分析来探索其在预后，诊断和免疫学中的功能。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：样品的转录组测序和临床数据是从癌症基因组图集（TCGA），基因型 - 组织表达项目（GTEX），人蛋白质图集（HPA），cBioportal，Timer，TiSIDB数据库中获得的。采用生物信息学方法来研究ITGAV的潜在致癌性，专门研究消化系统癌症中ITGAV的预后，诊断价值和免疫浸润水平的分析。此外，GO，KEGG和PPI网络分析揭示了与ITGAV相关的生物学功能和相关信号通路。最后，使用肝细胞癌和胰腺癌作为例子，通过实验验证了ITGAV在调节癌症进展中的作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们发现ITGAV在多种消化系统癌症中高度表达。此外，ITGAV的高表达与预后不良密切相关，并显示出早期诊断的潜力。确定了与细胞外基质组织过程和肿瘤迁移运动有关的途径。<i>在体外</i>，结果表明，ITGAV的敲低显着抑制了肝细胞癌和胰腺癌细胞的迁移运动能力，而其过表达显着促进了上述细胞的迁移。最后，免疫测定显示ITGAV表达与各种免疫细胞的浸润水平之间存在显着相关性，进一步阐明了ITGAV在肿瘤免疫微环境中的关键作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的结果阐明了ITGAV在预后评估，早期诊断和对消化系统癌症的免疫疗法中的重要性，并揭示了其在调节癌症进展中的多方面作用。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018050/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018050</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11864929/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11864929</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1480771>10.3389/fimmu.2025.1480771</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018050</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Xinyue shi</dc:creator><dc:creator> Jingyu Zang</dc:creator><dc:creator> Qi Gu</dc:creator><dc:creator> Mengmeng Zhang</dc:creator><dc:creator> Handi Sun</dc:creator><dc:creator> lijun Yang</dc:creator><dc:creator>贾胡岛</dc:creator><dc:creator>鲁恩·王（Ruonan Wang）</dc:creator><dc:creator>韩毛</dc:creator><dc:creator>Aitong Xu</dc:creator><dc:creator> XIN WANG</dc:creator><dc:creator> Yu Xiao</dc:creator><dc:creator> jialing cai</dc:creator><dc:creator>方汉</dc:creator><dc:creator>Depeng Yang</dc:creator><dc:creator> li</dc:creator><dc:creator> Huan Nie</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>ITGAV在消化系统癌症进展和免疫浸润中的多面作用的全面分析</dc:title><dc:identifier>PMID：40018050</dc:identifier><dc:identifier> PMC：PMC11864929</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1480771</dc:identifier></item><item><title>类风湿关节炎相关的类风湿因子在199</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018049/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>结论：类风湿关节炎相关的RF主要局限于类风湿关节炎，但是一些旋转后-19的人会产生一些中等水平的类风湿关节炎相关的RF，尤其是IGA同种型和同质曲线抗激素反应。这些发现完善了我们对RF的理解，提供了感染后免疫耐受性丧失的新见解，并揭示了临床前类风湿关节炎中生物标志物发育的新可能性。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1553540。 doi：10.3389/fimmu.2025.1553540。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：类风湿因子（RFS）是类风湿关节炎的标志，但在包括Covid-19在内的感染中也会出现。此外，感染再次包括在内，包括共vid-19，与类风湿关节炎发育有关，将RFS定位为感染与类风湿关节炎之间的潜在联系。传统上，RFS在整个条件下的反应性中被认为相对均匀，除了类风湿关节炎的反应性提高。然而，最近，在类风湿关节炎中鉴定出结合瓜氨酸和含有含有抗柑橘类IgG的IgG表位的IgG RF，但未发现其他自身免疫性疾病，而在结合特定的本地线性IgG表位的IgM RF中，发现了特定的本地线性IgG表位。这项研究的目的是确定类风湿关节炎相关的RFS是否发展在Covid-19，以便提供有关感染后免疫耐受性丧失的新见解。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在酶联的免疫吸附剂测定中使用了康复，类风湿关节炎和对照血清（n = 20），以评估IgG，IgM和IgA与八种IgG1肽中的citrulline-citrrull氨酸含量，含有柠檬酸含量的cit和citirulline-Cotocitrull和contrulline-Contrulline-Contrulline-Contrulline-contrulline-Contrulline-Contrulline-Contrulline-Contrulline-IgA结合。通过Kruskal-Wallis测试与Dunn的多重比较测试进行了比较抗体水平，并且通过Fisher的精确测试比较了具有比所有对照组大的参与者的数量。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：仅在类风湿关节炎中，在瓜氨酸或同尿氨酸特异性方式中，IgG与八个IgG1衍生的肽中的七个结合。 IgA结合在柑橘类或同型丙氨酸特异性的方式中以类风湿关节炎和19年含同挥发性肽的一种ciTrulline或copotrulline特异性方式增加到八个IgG1衍生的肽中的五个。比对照组的参与者多于以同义特异性方式升高IgG或IgA与两个IgG1衍生的肽的升高。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：类风湿关节炎相关的RF主要局限于类风湿关节炎，但是一些旋转后-19的人会产生一些中等水平的类风湿关节炎相关的RF，尤其是IGA同种型和同质曲线抗激素反应。这些发现完善了我们对RF的理解，提供了感染后免疫耐受性丧失的新见解，并揭示了临床前类风湿关节炎中生物标志物发育的新可能性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018049/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018049</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11864925/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11864925</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1553540>10.3389/fimmu.2025.1553540</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018049</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator>亚当·蒂蒂（Adam H Titi）</dc:creator><dc:creator> Braedon T Krisko</dc:creator><dc:creator> S Janna Bashar</dc:creator><dc:creator> Ryan R Adyniec</dc:creator><dc:creator>麦克斯韦H帕克</dc:creator><dc:creator>纳特·穆伦（Nat f Murren）</dc:creator><dc:creator>考特尼·B·迈赫（Courtney B Myhr）</dc:creator><dc:creator> Miriam A Shelef</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>类风湿关节炎相关的类风湿因子在199</dc:title><dc:identifier> PMID：40018049</dc:identifier><dc:identifier> PMC：PMC11864925</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1553540</dc:identifier></item><item><title>评估免疫检查点抑制剂在一线和二线治疗中的疗效和安全性，用于复发和转移性头部和颈部鳞状细胞癌：对RCT的系统评价和网络荟萃分析，重点是PD-L1表达</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018048/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>结论：这些结果表明，与R/M HNSCC患者相比，与SOC相比，免疫疗法可以改善生存结果，同时保持可比的安全性。对于患者，pembrolizumab与化学疗法和尼伏鲁明（Nivolumab）作为一线疗法可能是最佳选择，而nivolumab也表现出有望作为二线治疗。在PD-L1表达≥1％或≥20％的患者中，与化学疗法结合的pembrolizumab可能是首选的一线治疗，... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日; 16：1508885。 doi：10.3389/fimmu.2025.150885。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：这项研究系统地审查并进行了网络荟萃分析，以评估一线和二线免疫疗法对复发和转移性头部和颈部鳞状细胞癌（R/M HNSCC）的疗效和安全性。研究结果旨在提供有力的证据来指导临床决策。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们在PubMed，Embase，Cochrane Library和Web of Science进行了全面的文献搜索。结果度量包括总生存期（OS），无进展生存率（PFS），总反应率（ORR）以及3级或更高的不良事件（AES≥3）。为了比较各种一线和二线免疫疗法对具有不同PD-L1表达水平的R/M HNSCC的功效和安全性，我们进行了贝叶斯网络荟萃分析。这项研究在系统评价的前瞻性登记册（CRD42024551711）中进行了注册。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：该分析包括9项随机对照试验（RCT），涉及5,946例患者和7种免疫疗法方案。在R/M HNSCC的患者中，pembrolizumab与化学疗法作为一线治疗的pembrolizumab是唯一与SOC相比显示PFS益处的免疫疗法方案（HR = 0.92，95％CI：0.77-1.10）;但是，差异在统计上并不显着。同时，Nivolumab提供了最明显的OS益处（HR = 0.71,95％CI：0.52-0.98）。此外，pembrolizumab相对于SOC表现出最有利的安全性（OR = 0.12，95％CI：0.05-0.29）。在二线治疗中，Nivolumab在多个方面的表现超过了SOC，包括OS（HR = 0.68，95％CI：0.54-0.86），ORR（OR = 0.40，95％CI：0.17-0.95）和≥3级不良事件（OR = 0.32，95％，95％CI：0.32 CI：0.119-54）。 PD-L1表达的亚组分析表明，与SOC相比，Nivolumab对PD-L1表达≥1％的患者的一线治疗最大的OS益处（HR = 0.59，95％CI：0.34-1.00）作为一线治疗，而Pembrolizumab却与化学疗法（PEM-CHEMO）相结合（PEMBrolizumab均为95％co8 cosial pff s suble cosial cosial cosial cosial sand cosial cosial sand cosial sand cosial sand cosial; 0.67-1.00）。对于PD-L1表达≥20％的患者，PEM-CHEMO提供了最佳OS（HR = 0.60，95％CI：0.44-0.81）和PFS（HR = 0.73，95％CI：0.55-0.97）。此外，在PD-L1表达≥1％的患者中，Nivolumab作为二线治疗表明OS（HR = 0.55，95％CI：0.39-0.78）和PFS（HR = 0.59，95％CI：0.41-0.84）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这些结果表明，与R/M HNSCC患者相比，与SOC相比，免疫疗法可以改善生存结果，同时保持可比的安全性。对于患者，pembrolizumab与化学疗法和尼伏鲁明（Nivolumab）作为一线疗法可能是最佳选择，而nivolumab也表现出有望作为二线治疗。在PD-L1表达≥1％或≥20％的患者中，与化学疗法结合使用的Pembrolizumab可能是首选的一线治疗，而Nivolumab仍然是最有利的二线治疗。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">系统审查注册：https：//www.crd.york.ac.uk/prospero/，标识符CRD42024551711。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018048/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018048</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865193/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865193</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1508885>10.3389/fimmu.2025.150885</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018048</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Wei Chen</dc:creator><dc:creator> Qiance Wei</dc:creator><dc:creator> Tong Xiao</dc:creator><dc:creator> Jinghan Lai</dc:creator><dc:creator>孟芒黄</dc:creator><dc:creator>Yueran MA</dc:creator><dc:creator> Lili Zhang</dc:creator><dc:creator> Wenxin Xue</dc:creator><dc:creator> Shui Liu</dc:creator><dc:creator> Lichaoyue Sun</dc:creator><dc:creator> Wenshu li</dc:creator><dc:creator> Zhijun Bu</dc:creator><dc:creator> Junge Lou</dc:creator><dc:creator> Zhaolan Liu</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>评估免疫检查点抑制剂在一线和二线治疗中的疗效和安全性，用于复发和转移性头部和颈部鳞状细胞癌：对RCT的系统评价和网络荟萃分析，重点是PD-L1表达</dc:title><dc:identifier>PMID：40018048</dc:identifier><dc:identifier> PMC：PMC11865193</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.150885</dc:identifier></item><item><title> IRF1和CASP1的水平升高，作为克罗恩病的肠上皮细胞的热凋亡相关的生物标志物</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018047/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>结论：我们的发现将IRF1和CASP1确定为CD中IEC的关键凋亡相关生物标志物，这有助于理解CD发病机理中的凋亡。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1551547。 doi：10.3389/fimmu.2025.1551547。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：克罗恩氏病（CD）是一种复杂的炎症状况，有可能发生严重并发症。凋亡是程序性细胞死亡的一种炎症形式，而凋亡在CD的肠上皮细胞中的作用尚不清楚。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项研究中，通过差异表达分析，机器学习算法和单细胞测序分析，使用来自基因表达综合数据库的数据集鉴定了与凋亡相关的中心基因。使用临床样品和三硝基苯磺酸（TNBS）诱导的结肠炎大鼠模型验证集线器基因表达。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：鉴定了六个与凋亡相关的枢纽基因（ <i>CASP1，IRF1，ZBP1，MLKL，MMP1，HTRA1</i> ）。 <i>IRF1</i>和<i>CASP1</i>在CD中表现出显着的上调，包括结肠和回肠亚型，在不同的CD亚型中具有良好的诊断值。此外，除溃疡性结肠炎外，这两个基因在任何其他肠道疾病中均未升高。单细胞测序分析表明，肠上皮细胞（IEC）和单核细胞之间存在显着相互作用。临床样品进一步证实，与健康对照组相比，CD患者的<i>IRF1</i>和<i>CASP1</i>的mRNA水平明显更高。此外，大鼠大鼠模型验证了在mRNA和蛋白质水平上均在IRF1和Casp1上的上调。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的发现将<i>IRF1</i>和<i>CASP1</i>确定为CD中IEC的关键凋亡相关生物标志物，这有助于理解CD发病机理中的凋亡。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018047/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018047</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865233/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865233</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1551547>10.3389/fimmu.2025.1551547</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018047</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Xiaofang Xu</dc:creator><dc:creator>小lv</dc:creator><dc:creator> Ruizhi Zeng</dc:creator><dc:creator> Zhixi黄</dc:creator><dc:creator>Ziqian黄</dc:creator><dc:creator>Bing Han</dc:creator><dc:creator> lin</dc:creator><dc:creator>简·林</dc:creator><dc:creator>李·李</dc:creator><dc:creator>Junhua粉丝</dc:creator><dc:creator>小lv</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>IRF1和CASP1的水平升高，作为克罗恩病的肠上皮细胞的热凋亡相关的生物标志物</dc:title><dc:identifier>PMID：40018047</dc:identifier><dc:identifier> PMC：PMC11865233</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1551547</dc:identifier></item><item><title>新型mRNA疫苗可诱导有效的免疫原性并提供针对结核病的保护</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018046/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>简介：结核分枝杆菌（MTB）是结核病（TB）的病因，这是一种严重的全球负担。 MTB的棘手性阻止了对TB的保护明确相关性，并阻碍了迫切需要的新型TB疫苗的发展。脂质纳米颗粒（LNP）构造的mRNA是一个高度有希望的疫苗平台，尚未彻底应用于TB。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1540359。 doi：10.3389/fimmu.2025.1540359。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：<i>结核分枝杆菌</i>（ <i>MTB</i> ）是结核病（TB）的病因，这是一种严重的全球负担。 <i>MTB</i>的棘手性阻止了对TB的保护明确相关性，并阻碍了迫切需要的新型TB疫苗的发展。脂质纳米颗粒（LNP）构造的mRNA是一个高度有希望的疫苗平台，尚未彻底应用于TB。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们选择了五种<i>MTB</i>抗原（PPE15，ESAT6，ESPC，ESXI，Mete），并评估了它们作为LNP形成的mRNA疫苗的潜力，两者都单独递送时，当所有五个抗原均递送时，所有五个抗原均合并为混合物（M-MIX）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：每个mRNA构建体均显示出独特的细胞和体液免疫原性，并且M-MIX以及单抗原ESXI在鼠<i>MTB</i>挑战模型中赋予了明显的保护。虽然将每个mRNA的有效免疫反应用于促进BCG，但BCG的疗效没有增加。 M-MIX与重组，复制缺陷的黑猩猩腺病毒（Chadox1）（Chadox1）在异源促进递送（CM-MIX）中的组合似乎会导致对鼠<i>MTB</i>感染的保护增加，而不是单独使用任何一种治疗方案。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">讨论：这项工作值得进一步研究LNP形成的TB的MRNA疫苗，同时表明M-MIX和CM-MIX的潜力发展为疫苗开发的进一步阶段。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018046/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018046</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865049/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865049</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1540359>10.3389/fimmu.2025.1540359</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018046</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator>克里斯托弗·J·德·沃斯</dc:creator><dc:creator>Marcellus korompis</dc:creator><dc:creator> Shuailin li</dc:creator><dc:creator>艾伯塔省阿特雷</dc:creator><dc:creator>海伦·麦克沙恩（Helen McShane）</dc:creator><dc:creator> Elena Stylianou</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>新型mRNA疫苗可诱导有效的免疫原性并提供针对结核病的保护</dc:title><dc:identifier>PMID：40018046</dc:identifier><dc:identifier> PMC：PMC11865049</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1540359</dc:identifier></item><item><title>牛多形核中性粒细胞对&lt;em>; calicophoron daubneyi &lt;/em>;的细胞免疫反应&lt;/em>;</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018045/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>欧洲的Calicophoron daubneyi感染增加了，在某些地区比筋膜病更常见。感染发生在植被上存在的确定宿主摄入的摄入的肠car虫。经过脱身后，少年fluke液穿透小肠粘膜，并迁移到成年成年人成熟的瘤胃中。在整个躯体迁移中，少年遇到了不同的微环境和组织，并遇到宿主白细胞。除了吞噬作用外，产生反应性... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1515419。 doi：10.3389/fimmu.2025.1515419。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">欧洲的<i>Calicophoron daubneyi</i>感染增加了，在某些地区比筋膜病更常见。感染发生在植被上存在的确定宿主摄入的摄入的肠car虫。经过脱身后，少年fluke液穿透小肠粘膜，并迁移到成年成年人成熟的瘤胃中。在整个躯体迁移中，少年遇到了不同的微环境和组织，并遇到宿主白细胞。除吞噬作用外，活性氧（ROS）和脱粒的产生，多形核中性粒细胞还会施放中性粒细胞外陷阱（NETS），它们可能诱捕几种寄生虫物种，包括密切相关的肝Flukeiola <i>Hepatica</i> 。在这项研究中，我们分析了牛中性粒细胞<i>在体外</i>暴露于<i>Daubneyi</i>抗原（ <i>CD</i> AG）的体外暴露以及卵引发嗜中性粒细胞的激活和净形成。扫描电子显微镜（SEM）和免疫荧光分析的结果表明，在<i>CD</i> AG刺激的情况下，短散布网的形成弱，通过增加细胞外DNA测量值证实。同样，通过核区域扩张测定法证实了Netosis。用<i>CD</i> AG 100 µg/ml浓度促进牛中性粒细胞刺激导致氧消耗率显着增加（ <i>P</i> = 0.0152）和细胞外酸化速率（ <i>P</i> = 0.0022），而<i>CD</i> AG（10 µg/ml）较低浓度降低了中性粒细胞激活，这表明供应供应供应。这里研究的任何<i>CD</i> Ag浓度都不受细胞内和细胞外ROS的产生的影响。暴露于<i>CD</i> AG 100 µg/ml后，牛中性粒细胞总三磷酸浓度显着降低，与阳性对照（佛罗威尔菌霉菌/乙酸磷酸盐/离子霉素）一致。总而言之， <i>C。Daubneyi</i>激活具有较弱反应的牛中性粒细胞，这可能表明<i>daubneyi</i>特异性分子的释放（IE排泄分泌抗原，蛋白酶或核酸酶）可能会与中性粒细胞相关的效应机制相互作用。进一步的<i>离体</i>分析将通过证明中性粒细胞募集到受影响的肠粘膜中来阐明这种机制是否也参与了副膜组织的发病机理。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018045/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018045</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865088/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865088</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1515419>10.3389/fimmu.2025.1515419</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018045</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator>莉莉安娜先生席尔瓦</dc:creator><dc:creator>SaraLópez-Osorio</dc:creator><dc:creator>拉奎尔·皮克索（Raquel Peixoto）</dc:creator><dc:creator> Ershun Zhou</dc:creator><dc:creator>加布里埃尔·埃斯皮诺萨（Gabriel Espinosa）</dc:creator><dc:creator> UlrichGärtner</dc:creator><dc:creator>安贾·陶伯特（Anja Taubert）</dc:creator><dc:creator>伊万·科尼奥斯（IvánConejeros）</dc:creator><dc:creator>卡洛斯·赫莫西拉（Carlos Hermosilla）</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>牛多形核中性粒细胞对&lt;em>; calicophoron daubneyi &lt;/em>;的细胞免疫反应&lt;/em>;</dc:title><dc:identifier> PMID：40018045</dc:identifier><dc:identifier> PMC：PMC11865088</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1515419</dc:identifier></item><item><title>单核细胞衍生的Langerhans细胞表达由肽聚糖和白介素-4介导的抑制诱导的三角洲样4</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018044/?utm_source = chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description> T细胞有助于免疫疗法和自身免疫发病机理，Langerhans细胞（LCS）具有激活T细胞的实质性能力。体外生成的单核细胞衍生的LCS（MO-LCS）是研究自身免疫性疾病中LC功能并测试未来LC的免疫疗法的有用模型。尽管表达高水平的Delta样4（DLL4^（+）DC）的树突状细胞（DCS）是Notch配体家族的成员，其能力比DLL4^（ - ）DC激活T细胞，诱导... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1532620。 doi：10.3389/fimmu.2025.1532620。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> T细胞有助于免疫疗法和自身免疫发病机理，Langerhans细胞（LCS）具有激活T细胞的实质性能力。<i>体外</i>生成的单核细胞衍生的LCS（MO-LCS）是研究自身免疫性疾病中LC功能并测试未来LC的免疫疗法的有用模型。尽管表达高水平的Delta样4（DLL4 <sup>+</sup> DC）的树突状细胞（DCS）是Notch配体家族的成员，其能力比DLL4 <sup>-DC</sup>激活T细胞的能力更大，但人类DLL4 <sup>+</sup> DC的诱导方法尚未确定。这项研究的目的是确定MO-LCS是否表达DLL4并建立抗原呈递细胞的诱导方法，该方法最有效地激活T细胞，类似于我们先前建立的人类MO-LCS的诱导方法。我们比较了单核细胞衍生细胞之间通过流式细胞术的DLL4表达和T细胞激活的比率，这些细胞比驻留细胞具有更大的能力激活T细胞。在这里，我们发现MO-LCS表达的DLL4，这些DLL4在单核细胞衍生的细胞中最有效激活T细胞，并且MO-LCS和DLL4的表达是由DLL4，粒细胞巨噬细胞刺激性刺激因子诱导的，并转化了生长因子-β1。此外，DLL4表达需要肽聚糖，而白介素4抑制了肽聚糖。这些发现为表达DLL4 <sup>+</sup> MO-LC等表达DLL4细胞在人类疾病中的作用提供了见解，这将有助于未来发展更有效的治疗策略。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018044/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018044</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865044/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865044</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1532620>10.3389/fimmu.2025.1532620</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018044</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> rei ono</dc:creator><dc:creator> Kohei Maeda</dc:creator><dc:creator> Toshihiro Tanioka</dc:creator><dc:creator>服用异泽</dc:creator><dc:date>2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>单核细胞衍生的Langerhans细胞表达由肽聚糖和白介素-4介导的抑制诱导的三角洲样4</dc:title><dc:identifier> PMID：40018044</dc:identifier><dc:identifier> PMC：PMC11865044</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1532620</dc:identifier></item><item><title>与神经元抗体有关的自身免疫性小脑共济失调的临床特征</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018043/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>结论：ACA可以通过感染诱导或加剧。神经元抗体的检测对于精确诊断ACA至关重要。小脑系统症状，例如头晕，不稳定的步行，眼球震颤和构音障碍，是ACA的第一个和主要表现。 ACA患者的头部磁共振成像（MRI）可能正常或可能表现出异常，包括小脑萎缩和非特异性白质变化。免疫疗法在大多数...中可能是有效的... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1497695。 doi：10.3389/fimmu.2025.1497695。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：本研究旨在研究与自身免疫性小脑共济失调（ACA）有关的神经元抗体的临床特征，并为诊断和治疗该疾病提供指导。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：从2018年1月至2023年2月，从赫比大学附属医院接纳的抗体阳性ACA患者收集了人口统计学和临床​​数据。对临床表现，实验室检查，成像数据，治疗和预后进行了回顾性分析。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：这项研究总共六名患者，其中包括一名男性和五名女性，中位年龄为52.5岁。所有患者都出现头晕和步态异常，有或没有构造障碍。这些患者没有发现肿瘤。三名患者处于感染前阶段，而一名患者表现出ACA发烧症状和加重疾病表型。三名患者的抗谷氨酸脱羧酶（GAD）为阳性，而一名患者的抗TR，抗MGLUR1和抗Homer-3抗体为阳性。四名患者的白细胞（WBC）计数和脑脊液（CSF）的蛋白质水平增加，这与主要淋巴细胞炎症一致。一名患者显示了CSF特异性寡克隆蛋白的阳性信号。在六名患者中，有两名被诊断出患有双侧小脑萎缩，两名患者患有非特异性的白质变化。所有患者接受了免疫疗法和康复治疗。除本垒打3阳性患者外，其余患者的预后良好。一名患者复发。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：ACA可以通过感染诱导或加剧。神经元抗体的检测对于精确诊断ACA至关重要。小脑系统症状，例如头晕，不稳定的步行，眼球震颤和构音障碍，是ACA的第一个和主要表现。 ACA患者的头部磁共振成像（MRI）可能正常或可能表现出异常，包括小脑萎缩和非特异性白质变化。免疫疗法在大多数ACA患者中可能是有效的。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018043/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018043</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865250/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865250</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1497695>10.3389/fimmu.2025.1497695</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018043</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Yun Cai</dc:creator><dc:creator> Zhijuan Hua</dc:creator><dc:creator> Yanan Chen</dc:creator><dc:creator> Xue Chen</dc:creator><dc:creator> Na Liu</dc:creator><dc:creator>刘</dc:creator><dc:creator>Qianwen Zhou</dc:creator><dc:creator> Jinghua li</dc:creator><dc:creator> weiying di</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>与神经元抗体有关的自身免疫性小脑共济失调的临床特征</dc:title><dc:identifier>PMID：40018043</dc:identifier><dc:identifier> PMC：PMC11865250</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1497695</dc:identifier></item><item><title> 1-甲基二氨酰胺调节IL-10分泌和伏立康唑代谢</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018042/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>结论：1 mNA调节的库普弗细胞极化在LPS诱导的炎症环境中，减少了肝细胞中CYP2C38表达的炎症抑制，并促进了VRC代谢。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1529660。 doi：10.3389/fimmu.2025.1529660。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：炎症性疾病会损害伏立康唑（VRC）的肝代谢。在最近的研究中，1-甲基二甲酰胺（1-mNA）是肝脏中常见的烟酰胺的常见最终代谢产物。这项研究调查了1 mNA对肝脏中VRC代谢的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：脂多糖（LPS）诱导的全身性炎症反应的小鼠是胃内施用的1 mNA，并评估了其VRC代谢能力。分离了库普弗细胞和原发性肝细胞，并进行了流式细胞术以及分子敲低实验，以探索改善药物代谢的分子机制。 IL-10敲除（IL-10 <sup>- / -</sup> ）小鼠用于验证IL-10在炎症条件下增强肝细胞VRC代谢中的作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：1 mNA促进了肝库普弗细胞的M2极化，刺激IL-10分泌，在原代肝细胞中上调CYP2C38的表达以及增强的VRC代谢。 IL-10上调CYP2C38的机制似乎涉及肝细胞中核转录因子NF-κB（p65）的抑制。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：1 mNA调节的库普弗细胞极化在LPS诱导的炎症环境中，减少了肝细胞中CYP2C38表达的炎症抑制，并促进了VRC代谢。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018042/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018042</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865947/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865947</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1529660>10.3389/fimmu.2025.1529660</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018042</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator>小丹</dc:creator><dc:creator>Yuanqing li</dc:creator><dc:creator>林江</dc:creator><dc:creator>xuqiu xie</dc:creator><dc:creator>小王</dc:creator><dc:date>2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>1-甲基二氨酰胺调节IL-10分泌和伏立康唑代谢</dc:title><dc:identifier>PMID：40018042</dc:identifier><dc:identifier> PMC：PMC11865947</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1529660</dc:identifier></item><item><title>靶向氨基酸代谢以抑制胃癌进展并促进抗肿瘤免疫力：综述</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018041/?utm_source = chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>胃癌的发病率仍然很高，对人类健康构成了严重威胁。最近对肿瘤微环境中氨基酸代谢和免疫系统成分的全面研究阐明了肿瘤细胞，免疫细胞和氨基酸代谢之间的功能相互作用。这项研究回顾了氨基酸代谢在胃癌中的特征，特别关注蛋氨酸，半胱氨酸，谷氨酸，丝氨酸，...的代谢。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年2月13日； 16：1508730。 doi：10.3389/fimmu.2025.1508730。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">胃癌的发病率仍然很高，对人类健康构成了严重威胁。最近对肿瘤微环境中氨基酸代谢和免疫系统成分的全面研究阐明了肿瘤细胞，免疫细胞和氨基酸代谢之间的功能相互作用。这项研究回顾了胃癌中氨基酸代谢的特征，特别关注蛋氨酸，半胱氨酸，谷氨酸，丝氨酸，牛磺酸和其他氨基酸的代谢。它讨论了这些代谢过程，肿瘤发展和人体的抗肿瘤免疫力之间的关系，并分析了针对胃癌在化学疗法和免疫疗法中靶向氨基酸代谢的重要性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40018041/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018041</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11864927/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11864927</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1508730>10.3389/fimmu.2025.1508730</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40018041</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Yuchun Jiang</dc:creator><dc:creator>清道</dc:creator><dc:creator>Xuehan Qiao</dc:creator><dc:creator> Yufei Yang</dc:creator><dc:creator>彭彭</dc:creator><dc:creator>Miao Han</dc:creator><dc:creator>凯宾董</dc:creator><dc:creator>Wei Zhang</dc:creator><dc:creator>最小XU</dc:creator><dc:creator> Deqiang Wang</dc:creator><dc:creator> Wen Zhu</dc:creator><dc:creator> xiaoqin li</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>靶向氨基酸代谢以抑制胃癌进展并促进抗肿瘤免疫力：综述</dc:title><dc:identifier>PMID：40018041</dc:identifier><dc:identifier> PMC：PMC11864927</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1508730</dc:identifier></item><item><title> HIV-1 TAT诱导的上皮连接破坏以及口腔和生殖器上皮细胞的上皮间质转变会导致肿瘤细胞的侵袭性增加，疱疹病毒和巨细胞病毒的扩散</title><link/>https://pubmed.ncbi.nlm.nih.gov/40018040/?utm_source = chrome&amp;utm_medium = rsss&amp;utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250228091008＆v = 2.18.0.post9+e462414<description>人类免疫缺陷病毒（HIV-1）反式激活器TAT是一种独特的多功能病毒蛋白，被感染细胞分泌。 Although its primary function is to promote HIV-1 transcription, secreted Tat interacts with neighboring cells and induces numerous disease-associated pathological changes. Despite the substantial reduction of viral load and disease burden, Tat expression and secretion persist in people living with HIV who are undergoing treatment with highly effective combination... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Feb 13;16:1541532. doi: 10.3389/fimmu.2025.1541532.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Human immunodeficiency virus (HIV-1) transactivator Tat is a unique multi-functional viral protein secreted by infected cells. Although its primary function is to promote HIV-1 transcription, secreted Tat interacts with neighboring cells and induces numerous disease-associated pathological changes. Despite the substantial reduction of viral load and disease burden, Tat expression and secretion persist in people living with HIV who are undergoing treatment with highly effective combination antiretroviral therapy (cART). Tat interacts with both oral and genital epithelial cells and impairs their mucosal barrier functions, which facilitates the entry of other pathogenic viruses. Tat-mediated interactions with both human papillomavirus (HPV) -infected and HPV-negative neoplastic epithelial cells lead to epithelial-mesenchymal transition and increased invasiveness of malignant cells. Likewise, Tat-induced disruption of oral epithelial cell junctions leads to herpes simplex virus-1 (HSV-1) infection and spread via exposure of its receptor, nectin-1. HIV-1 Tat facilitates infection and spread of human cytomegalovirus (HCMV) by activating mitogen-activated protein kinases (MAPK) and promoting NF-κB signaling, both critical for the replication and production of progeny virions. HIV extracellular Tat also plays a critical role in human herpesvirus 8 (HHV8) -caused Kaposi sarcoma (KS) pathogenesis by synergizing with HHV-8 lytic proteins and promoting the proliferation, angiogenesis, and migration of endothelial cells. Collectively, these findings emphasize the critical impact of HIV-1 Tat on HIV/AIDS pathogenesis during the cART era and highlight the need for further research on the molecular mechanisms underlying Tat-mediated interactions with oral and genital mucosal epithelial cells.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40018040/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018040</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11866325/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11866325</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1541532>10.3389/fimmu.2025.1541532</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40018040</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Sharof Tugizov</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>HIV-1 Tat-induced disruption of epithelial junctions and epithelial-mesenchymal transition of oral and genital epithelial cells lead to increased invasiveness of neoplastic cells and the spread of herpes simplex virus and cytomegalovirus</dc:title><dc:identifier> pmid:40018040</dc:identifier><dc:identifier> pmc:PMC11866325</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1541532</dc:identifier></item><item><title> Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018039/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250228091008&amp;v=2.18.0.post9+e462414<description> CONCLUSION: The m7GRG-based prognostic model developed in this study holds strong clinical potential for predicting prognosis and therapeutic responses in HNSCC. The identification of LARP1 and its related regulatory pathways offers new avenues for targeted therapy in HNSCC. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Feb 13;16:1520070. doi: 10.3389/fimmu.2025.1520070.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: N7-methylguanosine (m7G) methylation is an RNA modification associated with cancer progression, but its specific role in head and neck squamous cell carcinoma (HNSCC) remains unclear. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: This study analyzed the differential expression of m7G-related genes (m7GRGs) in HNSCC using the TCGA-HNSCC dataset, identifying key pathways associated with the cell cycle, DNA replication, and focal adhesion. A LASSO-Cox regression model was constructed based on four m7GRGs (EIF3D, EIF1, LARP1, and METTL1) and validated with GEO datasets and clinical samples. Further validation of gene upregulation in HNSCC tissues was conducted using RT-qPCR and immunohistochemistry, while the role of LARP1 in HNSCC cells was assessed via knockout experiments. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: The constructed model demonstrated strong predictive performance, with the risk score significantly correlating with prognosis, immune infiltration, and drug sensitivity. An external dataset and clinical specimens further confirmed the model&#39;s predictive accuracy for immunotherapy response. Additionally, two regulatory axes-LINC00707/hsa-miR-30b-5p/LARP1 and SNHG16/hsa-miR-30b-5p/LARP1-were identified. LARP1 knockout experiments revealed that suppressing LARP1 markedly inhibited HNSCC cell proliferation, migration, and invasion. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: The m7GRG-based prognostic model developed in this study holds strong clinical potential for predicting prognosis and therapeutic responses in HNSCC. The identification of LARP1 and its related regulatory pathways offers new avenues for targeted therapy in HNSCC.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40018039/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018039</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11864954/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11864954</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1520070>10.3389/fimmu.2025.1520070</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40018039</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Juan Xu</dc:creator><dc:creator> Zihao You</dc:creator><dc:creator> Zhongping Zhu</dc:creator><dc:creator> Min Liu</dc:creator><dc:creator> Zheng Zhang</dc:creator><dc:creator> Panpan Xu</dc:creator><dc:creator> Juanjuan Dong</dc:creator><dc:creator> Yuting Huang</dc:creator><dc:creator> Chao Wang</dc:creator><dc:creator> Haotian Qin</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma</dc:title><dc:identifier> pmid:40018039</dc:identifier><dc:identifier> pmc:PMC11864954</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1520070</dc:identifier></item><item><title> Designing a potent multivalent epitope vaccine candidate against &lt;em>;Orientia tsutsugamushi&lt;/em>; via reverse vaccinology technique - bioinformatics and immunoinformatic approach</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018038/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250228091008&amp;v=2.18.0.post9+e462414<description> Scrub typhus is a life-threatening, undifferentiated febrile illness caused by a gram-negative bacterium, Orientia tsutsugamushi. The bacterial strain is a global health concern that should be considered. Despite several years of effort for the development of an effective immunogenic vaccine, no successful licensed vaccine is available. The aim of the study is to construct an epitope response using a reverse vaccinology approach. The TSA56 and ScaA proteins combined can be the most promising... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Feb 13;16:1513245. doi: 10.3389/fimmu.2025.1513245.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Scrub typhus is a life-threatening, undifferentiated febrile illness caused by a gram-negative bacterium, <i>Orientia tsutsugamushi</i> . The bacterial strain is a global health concern that should be considered. Despite several years of effort for the development of an effective immunogenic vaccine, no successful licensed vaccine is available. The aim of the study is to construct an epitope response using a reverse vaccinology approach. The TSA56 and ScaA proteins combined can be the most promising subunit vaccine candidates against <i>O. tsutsugamushi</i> . B-cell, CTL, and HTL epitopes were predicted, and subsequently, all the epitopes were linked by KK, AAY, and GPGPG linkers, respectively, along with an adjuvant at the N-terminal region. Furthermore, molecular docking and MD simulations were performed that exhibited a higher affinity towards TLR-2. A total of 16 linear B-cells, 6 CTL, and 2 HTL epitopes were identified and validated. The final vaccine construct showed high antigenicity, stability, and solubility. Molecular docking and MD simulations indicated strong binding interactions with TLR-2 and a stable vaccine-receptor complex. The expression of the vaccine in pET28a (+) vector was successfully implemented via in silico cloning as well as significant results from immune simulation demonstrated the efficacy of the vaccine in the immune cell interaction during the innate and adaptive immune responses immune simulation. In conclusion, the outcome suggested that the newly developed vaccine will be a promising candidate for controlling and providing definitive preventive measures against scrub typhus if further investigation is conducted experimentally.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40018038/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018038</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11865050/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11865050</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1513245>10.3389/fimmu.2025.1513245</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40018038</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Subhasmita Panda</dc:creator><dc:creator> Subrat Kumar Swain</dc:creator><dc:creator> Basanta Pravas Sahu</dc:creator><dc:creator> Soumya Ranjan Mahapatra</dc:creator><dc:creator> Jyotirmayee Dey</dc:creator><dc:creator> Rachita Sarangi</dc:creator><dc:creator> Anu Vinod Ranade</dc:creator><dc:creator> Namrata Mishra</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Designing a potent multivalent epitope vaccine candidate against &lt;em>;Orientia tsutsugamushi&lt;/em>; via reverse vaccinology technique - bioinformatics and immunoinformatic approach</dc:title><dc:identifier> pmid:40018038</dc:identifier><dc:identifier> pmc:PMC11865050</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1513245</dc:identifier></item><item><title> Effects of maternal-offspring supplementation of probiotics and synbiotics on the immunity of offspring Bama mini-pigs</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018037/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250228091008&amp;v=2.18.0.post9+e462414<description> Maternal nutrition is one of the main factors regulating the growth and immunity of piglets. This study aimed to investigate the effects of maternal or maternal-offspring supplementation of antibiotics, probiotics, and synbiotics on the immunity of offspring (21, 65, and 125 day-old) in Bama mini-pigs. The results showed that adding antibiotics to maternal diets increased the plasma IFN-γ level of offspring piglets at 21 day-old. Compared with maternal supplementation, maternal-offspring... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Feb 13;16:1507080. doi: 10.3389/fimmu.2025.1507080.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Maternal nutrition is one of the main factors regulating the growth and immunity of piglets. This study aimed to investigate the effects of maternal or maternal-offspring supplementation of antibiotics, probiotics, and synbiotics on the immunity of offspring (21, 65, and 125 day-old) in Bama mini-pigs. The results showed that adding antibiotics to maternal diets increased the plasma IFN-γ level of offspring piglets at 21 day-old. Compared with maternal supplementation, maternal-offspring supplementation of antibiotics decreased the IL-10 level in the spleen, probiotics decreased IL-2, IL-10, and TNF-α levels in the ileum, and synbiotics decreased IL-10 and IFN-γ levels in the ileum of offspring piglets. Moreover, maternal-offspring antibiotics supplementation increased the IL-1β level in the ileum, while probiotics supplementation increased the IL-1β level in the spleen of offspring piglets. Maternal antibiotics supplementation increased the TNF-α level in the ileum at 95 day-old compared with maternal probiotics and synbiotics supplementation. Maternal-offspring antibiotics supplementation increased the IL-1β level in the ileum compared with the probiotics supplementation, while synbiotics supplementation increased the IL-6 level in the ileum than the probiotics and antibiotics supplementation at 95 day-old. Moreover, maternal-offspring probiotics supplementation increased the IL-1β level in the spleen of offspring pigs, which was higher than the maternal probiotics supplementation. These findings suggest that the immune function of the offspring piglets varied depending on the specific approach used for probiotics and synbiotics supplementation.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40018037/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018037</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11864950/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11864950</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1507080>10.3389/fimmu.2025.1507080</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40018037</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Sujuan Ding</dc:creator><dc:creator> Ting Ye</dc:creator><dc:creator> Md Abul Kalam Azad</dc:creator><dc:creator> Qian Zhu</dc:creator><dc:creator> Yating Liu</dc:creator><dc:creator> Bie Tan</dc:creator><dc:creator> Xiangfeng Kong</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Effects of maternal-offspring supplementation of probiotics and synbiotics on the immunity of offspring Bama mini-pigs</dc:title><dc:identifier> pmid:40018037</dc:identifier><dc:identifier> pmc:PMC11864950</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1507080</dc:identifier></item><item><title> Time-restricted feeding alleviates arthritis symptoms augmented by high-fat diet</title><link/> https://pubmed.ncbi.nlm.nih.gov/40018036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250228091008&amp;v=2.18.0.post9+e462414<description> Rheumatoid arthritis (RA) affects approximately 1% of the global population. Its hallmark symptoms include severe pain and joint stiffness, which significantly diminish life quality. RA&#39;s development is influenced by multiple factors including unhealthy lifestyle habits. Calorie-rich diets, particularly those high in fat and resulting in obesity, are associated with RA and exacerbate its symptoms. Consequently, dietary modifications are recommended as a complementary treatment.然而，... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Feb 13;16:1512328. doi: 10.3389/fimmu.2025.1512328.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Rheumatoid arthritis (RA) affects approximately 1% of the global population. Its hallmark symptoms include severe pain and joint stiffness, which significantly diminish life quality. RA&#39;s development is influenced by multiple factors including unhealthy lifestyle habits. Calorie-rich diets, particularly those high in fat and resulting in obesity, are associated with RA and exacerbate its symptoms. Consequently, dietary modifications are recommended as a complementary treatment. However, adherence is often low due to the restrictive changes required in nutrient composition or caloric intake. Our previous findings indicate that time-restricted feeding (TRF) benefits leukocyte rhythm and mitigates autoimmune responses. In this study we explored the impact of TRF on the severity of K/BxN serum-transfer arthritis (STA) in mice subjected to high-fat diet. Three feeding schedules were implemented: a control (Ctrl) with constant access to standard chow, a high-fat diet group (HF) with <i>ad libitum</i> food access, and a high-fat TRF group (HF-TRF) with a 10-hour feeding window during the active phase. After four weeks of conditioning, STA was induced. Although macroscopic markers of inflammation did not differ between the Ctrl and HF groups, histological analysis revealed increased inflammation in HF mice, including expanded edema, pannus formation, bone erosion, elevated synovial neutrophil infiltration and serum leptin levels. Importantly, all these inflammatory markers were significantly reduced in the HF-TRF group, along with synovial IL-1β and monocyte/macrophage counts. Our results indicate that TRF can diminish the impact of a high-fat diet on STA severity, potentially serving as a preventive method and a sustainable therapeutic support for RA management.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40018036/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">40018036</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11864949/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250228091008&v=2.18.0.post9+e462414">PMC11864949</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1512328>10.3389/fimmu.2025.1512328</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40018036</guid><pubDate> Fri, 28 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Zsófia Búr</dc:creator><dc:creator> Bernadett Vendl</dc:creator><dc:creator> Ágnes R Sűdy</dc:creator><dc:creator> Zalán Lumniczky</dc:creator><dc:creator> Csongor G Szántó</dc:creator><dc:creator> Attila Mócsai</dc:creator><dc:creator> Krisztina Káldi</dc:creator><dc:creator> Krisztina Ella</dc:creator><dc:date> 2025-02-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Time-restricted feeding alleviates arthritis symptoms augmented by high-fat diet</dc:title><dc:identifier> pmid:40018036</dc:identifier><dc:identifier> pmc:PMC11864949</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1512328</dc:identifier></item></channel></rss>